| British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith, JK Limdi, ... Gut 68 (Suppl 3), s1-s106, 2019 | 1952 | 2019 |
| Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease KM De Lange, L Moutsianas, JC Lee, CA Lamb, Y Luo, NA Kennedy, ... Nature genetics 49 (2), 256-261, 2017 | 1230 | 2017 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 907 | 2019 |
| Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study I Cleynen, G Boucher, L Jostins, LP Schumm, S Zeissig, T Ahmad, ... The Lancet 387 (10014), 156-167, 2016 | 839 | 2016 |
| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 577 | 2019 |
| Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics NT Ventham, NA Kennedy, ER Nimmo, J Satsangi Gastroenterology 145 (2), 293-308, 2013 | 377 | 2013 |
| The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing NA Kennedy, AW Walker, SH Berry, SH Duncan, FM Farquarson, P Louis, ... PloS one 9 (2), e88982, 2014 | 333 | 2014 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 331 | 2015 |
| HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 324 | 2020 |
| British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ... Gut 69 (6), 984-990, 2020 | 291 | 2020 |
| MicroRNAs: new players in IBD R Kalla, NT Ventham, NA Kennedy, JF Quintana, ER Nimmo, AH Buck, ... Gut 64 (3), 504-513, 2015 | 286 | 2015 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 266 | 2021 |
| Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway JC Lee, M Espéli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ... Cell 155 (1), 57-69, 2013 | 262 | 2013 |
| Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD NA Kennedy, S Lin, JR Goodhand, N Chanchlani, B Hamilton, ... Gut 70 (10), 1884-1893, 2021 | 259 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 248 | 2021 |
| Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease J Torres, RK Boyapati, NA Kennedy, E Louis, JF Colombel, J Satsangi Gastroenterology 149 (7), 1716-1730, 2015 | 230 | 2015 |
| Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 228 | 2016 |
| Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7 Y Luo, KM De Lange, L Jostins, L Moutsianas, J Randall, NA Kennedy, ... Nature genetics 49 (2), 186-192, 2017 | 207 | 2017 |
| Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway ER Nimmo, JG Prendergast, MC Aldhous, NA Kennedy, P Henderson, ... Inflammatory bowel diseases 18 (5), 889-899, 2012 | 207 | 2012 |
| Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome I Trbojević Akmačić, NT Ventham, E Theodoratou, F Vučković, ... Inflammatory bowel diseases 21 (6), 1237-1247, 2015 | 203 | 2015 |
Jack SatsangiProfessor of Gastroenterology在 ed.ac.uk 的电子邮件经过验证
